Testing effectiveness (Phase 2)Active Not RecruitingNCT06912633
What this trial is testing
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Who this might be right for
Retinitis Pigmentosa
jCyte, Inc 31